"FDA Once Again Expands Recall of Blood Pressure Drugs" - Linda Carroll
The Food and Drug Administration has once again expanded its recall of widely prescribed blood pressure drugs because of contamination with a chemical linked to cancer. The latest recall targets 32 lots of the drug losartan sold by Macleods Pharmaceuticals. According to Prashant Vaishnava, MD, assistant professor of medicine and cardiology at the Icahn School of Medicine at Mount Sinai, patients taking recalled drugs also shouldn’t worry about cancer risk, because the risk is ultimately low. He added, “If 8,000 people took the highest dose of the recalled batches for four years, there might be one additional cancer over the lifetime of those 8,000 people.”
— Prashant Vaishnava, MD, Assistant Professor, Medicine, Cardiology, Icahn School of Medicine at Mount Sinai
Skipping Breakfast May Compromise the Immune System
Feb 23, 2023 View All Press Releases
Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart
Oct 18, 2022 View All Press Releases.jpg)
